Insider · CIK 0001789673

Lehrer-Graiwer Joshua

Reports to the SEC for 4 companies · LIBERTY CORNER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001789673

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-23	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+64K sh	—	—	64,000
2023-02-21	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, PRESIDENT AND CEO	AAward	+600K sh	—	—	600,000
2022-02-16	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, PRESIDENT AND CEO	AAward	+650K sh	—	—	650,000
2021-06-29	LENZLENZ Therapeutics, Inc.C Conversion	Director, PRESIDENT AND CEO	CConversion	+8,126 sh	—	—	1,161,670
2021-06-29	LENZLENZ Therapeutics, Inc. · Series B Preferred StockC Conversion	Director, PRESIDENT AND CEO	CConversion	−19.8K sh	—	—	0
2021-03-17	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, PRESIDENT AND CEO	AAward	+795K sh	—	—	795,196
2021-03-17	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, PRESIDENT AND CEO	AAward	+341K sh	—	—	340,798
2021-03-11	LENZLENZ Therapeutics, Inc. · Series B Preferred StockA Award	Director, PRESIDENT AND CEO	AAward	+19.8K sh	$5.06	+$100K	19,763
2021-01-16	LENZLENZ Therapeutics, Inc.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+374K sh	$0.30	+$112K	1,153,544
2021-01-16	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−374K sh	—	—	0
2021-01-13	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, PRESIDENT AND CEO	AAward	+374K sh	—	—	374,013
2020-03-09	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+938 sh	$19.89	+$18.7K	3,533
2020-03-09	Global Blood Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−938 sh	$59.90	−$56.2K	2,595
2020-03-09	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−938 sh	—	—	1,875
2020-03-05	Global Blood Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,138 sh	$65.30	−$74.3K	2,595
2020-03-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,750 sh	—	—	4,345
2020-03-01	Global Blood Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−612 sh	$63.96	−$39.1K	3,733
2020-03-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,750 sh	—	—	3,500
2020-02-18	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,313 sh	$26.90	+$35.3K	3,908
2020-02-18	Global Blood Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,313 sh	$69.71	−$91.5K	2,595
2020-02-18	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,313 sh	—	—	5,250
2020-02-10	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+625 sh	$12.95	+$8,093.75	3,220
2020-02-10	Global Blood Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−625 sh	$70.48	−$44.1K	2,595
2020-02-10	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−625 sh	—	—	0
2020-02-06	Global Blood Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,937 sh	$72.40	−$285K	2,595
2020-02-03	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,188 sh	$48.44	+$106K	8,720
2020-02-03	Global Blood Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,188 sh	$62.81	−$137K	6,532
2020-02-03	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,657 sh	$59.60	+$98.8K	8,189
2020-02-03	Global Blood Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,657 sh	$65.00	−$108K	6,532
2020-02-03	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,657 sh	—	—	13,250
2020-02-03	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,188 sh	—	—	26,250
2020-02-03	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+24.2K sh	—	—	24,160
2020-02-03	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+38.5K sh	—	—	38,500
2020-02-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,100 sh	—	—	8,695
2020-02-01	Global Blood Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−2,163 sh	$65.26	−$141K	6,532
2020-02-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,037 sh	—	—	3,113
2020-02-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,125 sh	—	—	8,500
2020-02-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,938 sh	—	—	17,625
2020-01-31	Global Blood Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+579 sh	$36.68	+$21.2K	2,595
2020-01-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+781 sh	$27.90	+$21.8K	2,797
2020-01-27	Global Blood Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−781 sh	$71.15	−$55.6K	2,016
2020-01-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−781 sh	—	—	4,688
2019-12-13	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,000 sh	—	—	4,000
2019-12-13	Global Blood Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−1,984 sh	$76.88	−$153K	2,016
2019-12-13	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,000 sh	—	—	0
2019-12-09	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+937 sh	$19.89	+$18.6K	937
2019-12-09	Global Blood Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−937 sh	$78.50	−$73.6K	0
2019-12-09	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−937 sh	—	—	2,813
2019-11-26	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+11.6K sh	$59.60	+$691K	11,593
2019-11-26	Global Blood Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−11.6K sh	$67.19	−$779K	0

Recent filings

Accepted (ET)
May 14
Lehrer-Graiwer Joshua0001193125-26-201468
SEC(opens sec.gov)
Feb 234
Lehrer-Graiwer Joshua0001209191-23-012259
SEC(opens sec.gov)
Feb 184
Lehrer-Graiwer Joshua0001209191-22-011470
SEC(opens sec.gov)
Jul 14
Lehrer-Graiwer Joshua0000899243-21-027011
SEC(opens sec.gov)
Mar 94
Lehrer-Graiwer Joshua0000899243-20-007676
SEC(opens sec.gov)
Mar 44
Lehrer-Graiwer Joshua0000899243-20-007085
SEC(opens sec.gov)
Feb 204
Lehrer-Graiwer Joshua0000899243-20-005350
SEC(opens sec.gov)

Companies

Address

C/O LISATA THERAPEUTICS, INC. P.O. BOX 173

LIBERTY CORNER, NJ, 07938